Characterization of HIV-1 Antibody Resistance in Patients - HIVAR

niversitätsklinikum Köln0 个研究点目标入组 210 人开始时间: 2022年1月10日最近更新: 2024年8月19日

适应症

试验速览

暂无简介。

•Only for blood draws >100ml:
•- Hemoglobin <13.5 g/dL (men) or <12.5 g/dL (women)
•- Symptomatic heart disease (e.g., heart failure NYHA =II, coronary artery disease,
•previous myocardial infarction).
•- Has had a myocardial infarction.
•- Stage GOLD III-IV COPD.
•- Body weight less than 45kg (To perform a blood draw of =250 mL
•there must be a body weight of at least 50 kg)
•- <8 weeks (men) or <12 weeks (women) since last blood volume draw of =500 mL
•- Known acquired or hereditary coagulation disorder, including therapeutic Anticoagulation
•- Within one week of a minor surgery (e.g., biopsy, tooth extraction, etc.), or one month after major surgery (e.g., opening of the chest cavity or abdomen) or other surgery with increased risk of postoperative bleeding (e.g., removal of the palatine tonsils [tonsillectomy]).
•- Current participation in an interventional study. Current participation is defined as when the patient is in the treatment or follow-up phase of a clinical trial, or when another interventional procedure has been performed or is planned for another type of study in temporal relation to the leukapheresis or blood collection. In the latter case, it is crucial that an overlap of study-related harms or a disproportionate burden for the patient is excluded from a medical point of view.

发起方

niversitätsklinikum Köln